EAMS Group Revenue and Competitors

London, UK

Location

N/A

Total Funding

Consulting

Industry

Estimated Revenue & Valuation

  • EAMS Group's estimated annual revenue is currently $2M per year.(i)
  • EAMS Group's estimated revenue per employee is $132,000

Employee Data

  • EAMS Group has 15 Employees.(i)
  • EAMS Group grew their employee count by -29% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.1M10%N/AN/A
#2
$57.6M23828%N/AN/A
#3
$334.5M108643%N/AN/A
#4
$259.2M82428%$346MN/A
#5
$13.1M660%N/AN/A
#6
$50.1M20747%N/AN/A
#7
$19.8M907%N/AN/A
#8
$2M15-21%N/AN/A
#9
$57.6M2382%N/AN/A
#10
$7.9M455%N/AN/A
Add Company

EAMS Group enable the transformation of your organisation through Enterprise Asset & Safety Management. Providing your journey to world class performance & digital asset management across the entire asset lifecycle. Utilising the ‘EAMS Group Digital Transformation Centre'​, clients can transform their organisations to attain world class performance, minimising business risk and optimising ROI, whilst driving down operating costs and improving reliability, safety and performance. At EAMS Group we understand that to successfully implement Enterprise Asset Management (EAM) systems, it requires more than just implementing the information system, it is the business transformation and culture change that occurs when the business adopts a fully integrated Asset and Safety Management philosophy. Using our suite of proven frameworks and methodologies we ensure that the program structure, governance, ownership and delivery is understood and adhered to and the expected change and benefits are delivered. Our delivery model provides business transformation to World Class Asset and Safety Management putting the EAM system at the heart of this transformation.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EAMS Group News

2022-04-17 - Pharming receives agreement of Paediatric Investigation Plan ...

... candidate for the MHRA's Early Access to Medicines Scheme (EAMS), ... Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a...

2022-04-06 - Risankizumab - Information for NHS Medical Director

The aim of the Early Access to Medicines Scheme (EAMS) is to provide earlier ... Groups (EAGs) and the Commission on Human Medicines (CHM):.

2022-03-30 - Lutetium (177Lu) vipivotide tetraxetan in the treatment of ...

For the full EAMS indication please see section 4.1 of the Treatment ... contact the Welsh Government Health and Social Services Group by...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M15-21%N/A
#2
$1.3M15-25%N/A
#3
$2.3M15-29%N/A
#4
$2.2M15-12%N/A
#5
$2.3M15-21%N/A